Vi T. Pham
Parkville, VIC 3052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
The Design, Synthesis and Pharmacological Characterization of Potent Xanomeline-Based M1 and M4 mAChR Bitopic Ligands.
Journal: Journal of medicinal chemistry
Published: July 27, 2026
Low Agonism and Balanced Pathway Modulation Distinguish an M1 Muscarinic Receptor Positive Allosteric Modulator Lacking Cholinergic Adverse Effects.
Journal: ACS chemical neuroscience
Published: June 30, 2026
Structure-guided allosteric modulation of the delta opioid receptor.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
A Structure-Activity Relationship Study of Novel Positive Allosteric Modulators for the δ-Opioid Receptor.
Journal: ACS chemical neuroscience
Published: July 18, 2025
A cross-correlator-based timing tool for FemtoMAX.
Journal: Journal of synchrotron radiation
Published: October 20, 2024
Beta-lactam allergy risk stratification in a maternity population in Australia: Scope for allergy de-labelling.
Journal: The Australian & New Zealand journal of obstetrics & gynaecology
Published: January 11, 2024
Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR.
Journal: Nature communications
Published: March 08, 2023
Author Correction: Structural basis of efficacy-driven ligand selectivity at GPCRs.
Journal: Nature chemical biology
Published: March 06, 2023
Role of Conserved Tyrosine Lid Residues in the Activation of the M2 Muscarinic Acetylcholine Receptor.
Journal: Molecular pharmacology
Published: December 07, 2022
Last Updated: 09/26/2026